- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Insider-Bought Value Plays
Taiwanese Pharmaceuticals & Biotech Insider-Bought Value Plays
Results
4
1 new
4 companies
HeXun Biosciences
Market Cap: NT$2.8b
Engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.
6986
NT$61.20
7D
-4.1%
1Y
-17.9%
Synbio Tech
Market Cap: NT$1.7b
Manufactures and sells human healthcare products and probiotics for animals.
1295
NT$50.00
7D
0%
1Y
-48.4%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.3b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$63.10
7D
2.4%
1Y
9.2%
3D Global Biotech
Market Cap: NT$1.9b
Manufactures and sells medical devices for human body reconstruction.
New
6808
NT$24.45
7D
-17.0%
1Y
-59.0%